• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    2.56 0.21(8.94%) Dec 17, 4:00PM EST
    |After Hours : 2.52 Down 0.04 (1.56%) Dec 17, 4:50PM EST
    Add to Portfolio
    Prev Close:2.35
    Open:2.34
    Bid:N/A
    Ask:2.59 x 300
    1y Target Est:2.96
    Beta:3.11
    Earnings Date:Mar 4 - Mar 9 (Est.)
    Day's Range:2.34 - 2.59
    52wk Range:1.00 - 8.46
    Volume:2,466,287
    Avg Vol (3m):2,846,920
    Market Cap:158.59M
    P/E (ttm):N/A
    EPS (ttm):-0.85
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNSS

    Comparison

    Symbol% ChgMkt Cap
    SNSSUp 8.94%158.59M
    AZN88.65B
    PFE196.08B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):21.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.85
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback